CDK1 and breast carcinoma: Leveraging bioinformatics tools and experimental validation, the research explores the interactions between C. urens components and key genes, including CDK1, CDC25A, and PLK1, which are crucial for cell cycle regulation and often dysregulated in breast cancer.